Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • NeuroSciences Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Saudi Medical Journal
  • Other Publications
    • NeuroSciences Journal
  • My alerts
  • Log in
Saudi Medical Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Research ArticleOriginal Article
Open Access

Effect of modified tumor antigen on experimentally induced sarcomas

Suresh K. Nigam and Venkatakrishna H. Bhatt
Saudi Medical Journal February 2001, 22 (2) 157-163;
Suresh K. Nigam
Departments of Environmental Carcinogens & Agricultural Health, Institute of Occupational Health (NIOH), Meghani Nagar, Ahmedabad, Gujarat, India.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Venkatakrishna H. Bhatt
Department of Agricultural Health, National Institute of Occupational Health, Meghani Nagar, Ahmedabad 380016, Gujarat, India. Tel. +91 (79) 2867351/2867352, 2866237. Fax. +91 (79) 2866630. E-mail: [email protected]:Grams:NIOHEALTH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Abstract

OBJECTIVE: To explore the possibility of controlling established tumors by active immunization through specific and nonspecific methods.

METHODS: By subcutaneous methylcholanthrene, a fibrosarcoma was produced in adult Swiss male mice. The fibrosarcoma was transplanted into the isogenic strain. The cleared tumor cells were injected subcutaneous into the hind leg of the 1st sarcoma group. The 2nd group received intraperitoneally sensitized spleen cells. One section of the irradiated 3rd tumor group received intraperitoneally sensitized spleen cells and subsequently a mild dose of modified tumor antigen. The 2nd section of the 3rd group was irradiated in between the administration of modified tumor antigen. In both the groups, liver of normal and transplanted tumor bearing mice was processed and intraperitoneally injected into the isogenic tumor bearing mice. Histopathology and tumor size by calipers was assessed.

RESULTS: The first group showed enhancement of tumor growth in all its 3 fractions injected at different intervals. In the 2nd group, the average survival period was prolonged. In the first section of the 3rd group a decrease in tumor size and protracted survival was noted. In the transplanted tumor bearing mice, complete suppression of tumor growth was observed. In the 2nd fraction of the 3rd group, long survival period with regression of tumor was observed. In the 4th group, attenuated tumor and one mouse was observed to become tumor free after 60 days.

CONCLUSION: Active immunosuppression by sensitized spleen cells and vaccines from transplanted sarcomas enabled regression of tumor size and longevity in tumor bearing mice. The modified tumor antigens, processed isogenic liver cells attenuated to zero level in tumor size in isogenic transplanted tumor bearing mice. The results show vaccines from allogenic and syngeneic sources bear the potential to regress tumor and enhance survival period.

  • Copyright: © Saudi Medical Journal

This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PreviousNext
Back to top

In this issue

Saudi Medical Journal: 22 (2)
Saudi Medical Journal
Vol. 22, Issue 2
1 Feb 2001
  • Table of Contents
  • Cover (PDF)
  • Index by author
Download PDF
Email Article

Thank you for your interest in spreading the word on Saudi Medical Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effect of modified tumor antigen on experimentally induced sarcomas
(Your Name) has sent you a message from Saudi Medical Journal
(Your Name) thought you would like to see the Saudi Medical Journal web site.
Citation Tools
Effect of modified tumor antigen on experimentally induced sarcomas
Suresh K. Nigam, Venkatakrishna H. Bhatt
Saudi Medical Journal Feb 2001, 22 (2) 157-163;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Effect of modified tumor antigen on experimentally induced sarcomas
Suresh K. Nigam, Venkatakrishna H. Bhatt
Saudi Medical Journal Feb 2001, 22 (2) 157-163;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The interaction between no folic acid supplementation during early pregnancy and preeclampsia increased the risk of preterm birth
  • The characteristics of Grave’s disease in children and adolescent patients in Al-Madinah Al-Munawwarah
  • Patellar height changes after treatment of tibia plateau fractures
Show more Original Article

Similar Articles

CONTENT

  • home

JOURNAL

  • home

AUTHORS

  • home
Saudi Medical Journal

© 2023 Saudi Medical Journal Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.

Powered by HighWire